Showing results (391-400 of 457) with videos related to
Sort By:
Pageof 46
Rheumatology (Oxford, England)|April 12, 2017
Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experimentMickaël Hiligsmann, Benedict G Dellaert, Carmen D Dirksen, et al.Hemasphere|January 18, 2021
Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents StudyMarie-Dominique Tabone, Sami Kolta, Pascal Auquier, et al.JBMR Plus|September 16, 2022
Protective Effect on Bone of Nacre Supplementation in Ovariectomized RatsDung Kim Nguyen, Norbert Laroche, Arnaud Vanden-Bossche, et al.Joint Bone Spine|June 10, 2018
Prealbumin, platelet factor 4 and S100A12 combination at baseline predicts good response to TNF alpha inhibitors in rheumatoid arthritisMinh Vu Chuong Nguyen, Athan Baillet, Xavier Romand, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 12, 2013
Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal womenYohann Bala, Roland Chapurlat, Angela M Cheung, et al.Scientific Reports|August 19, 2021
Lipidomic profile of human nasal mucosa and associations with circulating fatty acids and olfactory deficiencySpiro Khoury, Volker Gudziol, Stéphane Grégoire, et al.Experimental Gerontology|November 25, 2023
Dietary supplementation with nacre reduces cortical bone loss in aged female miceDung Kim Nguyen, Arnaud Vanden-Bossche, Norbert Laroche, et al.Journal of the American Geriatrics Society|January 29, 2013
Frailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of osteoporosis in womenSarah E Tom, Jonathan D Adachi, Frederick A Anderson, et al.Bone|September 12, 2012
Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohortPamela Guggina, Julie Flahive, Frederick H Hooven, et al.Seminars in Arthritis and Rheumatism|November 6, 2017
Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, FranceJérôme Avouac, Anna Moltó, Vered Abitbol, et al.Pageof 46